Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENCE: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Treatment of Cushing's syndrome is essential to reduce mortality and associated comorbidities. Effective treatment includes the normalization of cortisol levels or action. It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives). Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The guidelines provide a general definition of remission after resection of an ACTH-producing corticotroph tumor as morning serum cortisol levels <5 μg/dL (<138 nmol/L) or UFC <28-56 nmol/d (<10-20 μg/d) within 7 days of tumor resection (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Steroidogenesis inhibitors work by inhibiting one or more enzymes involved in steroidogenesis, decreasing cortisol and other steroid hormone production (37, 38).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Available medical therapies currently used in clinical practice to treat CS include medications from 3 classes: pituitary-directed therapies (for pituitary CD only), steroidogenesis inhibitors, and glucocorticoid receptor antagonists (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“In patients with CS, surgical resection of the causative lesion(s) is the first-line treatment option regardless of etiology.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Pituitary-directed therapies, including pasireotide (US/EU/Canada) and cabergoline (off-label use only), inhibit pituitary ACTH production and, in some cases, ectopic ACTH secretion from neuroendocrine tumors, thereby reducing downstream cortisol secretion (37, 128).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“(17) 2810 Nieman et al Guidelines on Cushing’s Syndrome Treatment J Clin Endocrinol Metab, August 2015, 100(8):2807–2831”
BackgroundSelf-citationKahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Self-citationPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Cited by
Items 201–300 of 1,000
Cohen-Cohen, S., Brown, D. A., Himes, B. T., Wheeler, L., Ruff, M. W., Major, B. T., Ospina, N. S., Atkinson, J. L. D., Meyer, F. B., Bancos, I., et al. (2020) · Journal of neurosurgery · doi:10.3171/2020.1.jns193538 · Cited by 37
Evaluation and Treatment of Patients With Hypercortisolism: A Review
Miller, B. S., & Auchus, R. J. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.3280 · Cited by 37
Endocrine Hypertension: A Practical Approach
Pappachan, J. M., & Buch, H. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_26 · Cited by 37
Armani, S., Ting, L. S. L., Sauter, N. P., Darstein, C., Tripathi, A. P., Wang, L., Zhu, B. Y., Gu, H., Chun, D. Y., Einolf, H. J., et al. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0497-0 · Cited by 37
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa107 · Cited by 36
“The therapeutic landscape with surgery, radiotherapy, and pharmacotherapy has improved dramatically over the past 30 years for CS and has resulted in better patient outcomes [23].”
BackgroundSelf-citationPrognostic Factors of Long-Term Remission After Surgical Treatment of Cushing’s Disease
Ioachimescu, A. G. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.002 · Cited by 36
Nachtigall, L. B., Karavitaki, N., Kiseljak‐Vassiliades, K., Ghalib, L. M., Fukuoka, H., Syro, L. V., Kelly, D. F., & Fleseriu, M. (2018) · Pituitary · doi:10.1007/s11102-018-0924-0 · Cited by 36
Zhao, P., Cheng, J., Li, B., Nie, D., Li, C., Gui, S., Wang, H., & Zhang, Y. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09570-0 · Cited by 36
The Application of Artificial Intelligence and Machine Learning in Pituitary Adenomas
Dai, C., Sun, B., Wang, R., & Kang, J. P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.784819 · Cited by 36
Long‐term follow‐up and predictors of recurrence of Cushing's disease
Guignat, L., & Bertherat, J. Y. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13186 · Cited by 36
Viecceli, C., Mattos, A. C. V., Hirakata, V. N., Garcia, S. P., Rodrigues, T. D. C., & Czepielewski, M. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1145775 · Cited by 35
Athimulam, S., Lazik, N., & Bancos, I. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.003 · Cited by 35
Medical therapy in severe hypercortisolism
Marques, J. V. O., & Boguszewski, C. L. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101487 · Cited by 35
MRI–Negative Cushing's Disease: A Review on Therapeutic Management
Sabahi, M., Shahbazi, T., Maroufi, S. F., Vidal, K., Recinos, P. F., Kshettry, V. R., Röser, F., Adada, B., & Borghei-Razavi, H. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.03.076 · Cited by 35
Recent Progress in the Medical Therapy of Pituitary Tumors
Langlois, F., McCartney, S., & Fleseriu, M. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.162 · Cited by 34
Corticotropin hormone assay interference: A case series
Donegan, D. M., Algeciras‐Schimnich, A., Hamidi, O., Young, W. F., Nippoldt, T. B., Bancos, I., & Erickson, D. Z. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.11.006 · Cited by 34
Adrenalectomy for Cushing's syndrome: do's and don'ts.
Păduraru, D. N., Nica, A. E., Carşote, M., & Valea, A. (2016) · PubMed Central · Cited by 34
Pre-operative serum inflammation-based scores in patients with pituitary adenomas
Marques, P., de Vries, F., Dekkers, O. M., van Furth, W. R., Korbonits, M., Biermasz, N. R., & Pereira, A. M. (2020) · Pituitary · doi:10.1007/s11102-020-01112-5 · Cited by 34
Zhang, W., Sun, M., Fan, Y., Wang, H., Feng, M., Zhou, S. K., & Wang, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635795 · Cited by 34
Pivonello, R., Elenkova, A. P., Fleseriu, M., Feelders, R. A., Witek, P., Greenman, Y., Geer, E. B., Perotti, P., Saiegh, L., Cohen, F. J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.595894 · Cited by 34
Geer, E. B., Shafiq, I., Gordon, M. B., Bonert, V., Ayala, A., Swerdloff, R. S., Katznelson, L., Lalazar, Y., Manuylova, E., Pulaski-Liebert, K. J., et al. (2017) · Endocrine Practice · doi:10.4158/ep171787.or · Cited by 33
“Forty-one percent of this cohort had initial surgical remission, which contrasts with previous reports that showed surgical remission rates of 73 to 76% for microadenomas and about 43% for macroadenomas (1,10,12-14).”
BackgroundResultSelf-citationMolecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome
Nieman, L. K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab046 · Cited by 33
Self-citationAssessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses
Yozamp, N., & Vaidya, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101491 · Cited by 33
Pharmacological Treatment of Cushing's Syndrome
Castinetti, F. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102908 · Cited by 33
Management of pituitary incidentaloma
Boguszewski, C. L., Musolino, N. R. D. C., & Kasuki, L. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.04.002 · Cited by 33
Pivonello, R., Ferrigno, R., Isidori, A. M., Biller, B. M. K., Grossman, A. B., & Colao, A. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30215-1 · Cited by 33
Self-citationCeccato, F., Tizianel, I., Vedolin, C. K., Boscaro, M., Barbot, M., & Scaroni, C. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa564 · Cited by 33
Prolactin and Other Pituitary Disorders in Kidney Disease
Huang, W., & Molitch, M. E. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.010 · Cited by 33
Vassiliadi, D. A., Balomenaki, M., Asimakopoulou, A., Botoula, E., Tzanela, M., & Tsagarakis, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2799 · Cited by 33
Gheorghiu, M. L., & Fleseriu, M. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.476 · Cited by 33
Radiotherapy as a tool for the treatment of Cushing’s disease
Castinetti, F., Brue, T. C., & Ragnarsson, Ó. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0092 · Cited by 33
Bengtsson, D., Ragnarsson, Ó., Berinder, K., Dahlqvist, P. M., Engström, B. E., Ekman, B., Höybye, C., Burman, P., & Wahlberg, J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab079 · Cited by 34
Fein, H. G., Vaughan, T. B., Kushner, H., Cram, D., & Nguyen, D. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0059-5 · Cited by 32
Pituitary Disorders in Pregnancy
Woodmansee, W. W. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.09.009 · Cited by 33
Liu, Z., Zhang, X., Wang, Z., You, H., Li, M. L., Feng, F., & Jin, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-71628-0 · Cited by 32
Wang, F., Catalino, M. P., Bi, W. L., Dunn, I. F., Smith, T. R., Guo, Y., Hordejuk, D., Kaiser, U. B., Laws, E. R., & Min, L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa773 · Cited by 32
Role of radiosurgery in the treatment of Cushing's disease
Losa, M., Albano, L., Bailo, M., Barzaghi, L. R., & Mortini, P. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13134 · Cited by 32
Nowotny, H. F., Braun, L., Vogel, F., Bidlingmaier, M., Reincke, M., Tschaidse, L., Auer, M. K., Lottspeich, C., Wudy, S. A., Hartmann, M. F., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0320 · Cited by 32
van Halem, K., Vrolijk, L., Pereira, A. M., & de Boer, M. G. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx002 · Cited by 32
Inferior petrosal sinus sampling in Cushing’s syndrome: usefulness and pitfalls
Vassiliadi, D. A., Mourelatos, P., Kratimenos, T., & Tsagarakis, S. (2021) · Endocrine · doi:10.1007/s12020-021-02764-4 · Cited by 31
An Individualized Approach to the Evaluation of Cushing Syndrome
Sharma, S. T. (2017) · Endocrine Practice · doi:10.4158/ep161721.ra · Cited by 31
Omar, A. T., Muñoz, D. G., Goguen, J., Lee, J. M., Rotondo, F., Kovács, K., & Cusimano, M. D. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106306 · Cited by 31
Ouyang, T., Zhang, N., Xie, S., Tang, B., Li, J., Xiao, L., Zhang, F.-B., Wu, B., Zhou, D., Li, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.693063 · Cited by 31
Synergistic cortisol suppression by ketoconazole–osilodrostat combination therapy
Amodru, V., Brue, T. C., & Castinetti, F. (2021) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-21-0071 · Cited by 31
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
Pivonello, C., Patalano, R., Negri, M., Pirchio, R., Colao, A. A. L., Pivonello, R., & Auriemma, R. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.791633 · Cited by 31
Vaccination of Immunocompromised Cats
Hartmann, K., Möstl, K., Lloret, A., Thiry, É., Addie, D., Belák, S., Boucraut‐Baralon, C., Egberink, H. F., Frymus, T., Hofmann‐Lehmann, R., et al. (2022) · Viruses · doi:10.3390/v14050923 · Cited by 31
Perioperative Management of Endocrine Active Adrenal Tumors
Schreiner, F., Anand, G., & Beuschlein, F. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0654-5251 · Cited by 31
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures
Ferraù, F., Giovinazzo, S., Messina, E., Tessitore, A., Vinci, S. L., Mazziotti, G., Lania, A. G., Granata, F., & Cannavò, S. (2019) · Endocrine · doi:10.1007/s12020-019-02034-4 · Cited by 31
Outcome in dogs undergoing adrenalectomy for small adrenal gland tumours without vascular invasion
Cavalcanti, J. V. J., Skinner, O. T., Mayhew, P. D., Colee, J., & Boston, S. E. (2020) · Veterinary and Comparative Oncology · doi:10.1111/vco.12587 · Cited by 31
Feasibility, safety, and outcomes of a stratified fast-track care trajectory in pituitary surgery
Lobatto, D. J., Vlieland, T. P. M. V., van den Hout, W. B., de Vries, F., de Vries, A. F., Schutte, P. J., Verstegen, M. J. T., Pereira, A. M., Peul, W. C., Biermasz, N. R., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02308-2 · Cited by 31
Charchar, H. L. S., & Fragoso, M. C. B. V. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac041 · Cited by 31
Sun, X., Feng, M., Lü, L., Zhao, Z., Bao, X., Deng, K., Yao, Y., Zhu, H., & Wang, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.600323 · Cited by 30
Adrenal Rests in the Uro-genital Tract of an Adult Population
Falco, E. C., Daniele, L., Metović, J., Bollito, E., Rosa, G. D., Volante, M., & Papotti, M. G. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09685-y · Cited by 30
A multidisciplinary approach to the management of adrenal incidentaloma
Voltan, G., Boscaro, M., Armanini, D., Scaroni, C. M., & Ceccato, F. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1948327 · Cited by 30
Pivonello, R., Münster, P. N., Terzolo, M., Ferrigno, R., Simeoli, C., Puglisi, S., Bali, U., & Moraitis, A. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.793262 · Cited by 30
E2F1-mediated human POMC expression in ectopic Cushing’s syndrome
Araki, T., Liu, N., Tone, Y., Ramos, D. C., Heltsley, R., Tone, M., & Melmed, S. K. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0206 · Cited by 30
Ceccato, F., Trementino, L., Barbot, M., Antonelli, G., Plebani, M., Denaro, L., Regazzo, D., Rea, F., Frigo, A. C., Concettoni, C., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13391 · Cited by 30
Zhang, C. D., Li, D., Singh, S., Suresh, M., Thangamuthu, K., Nathani, R., Achenbach, S. J., Atkinson, E. J., Van Gompel, J. J., Young, W. F., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad073 · Cited by 29
Trementino, L., Michetti, G., Angeletti, A., Marcelli, G., Concettoni, C., Cardinaletti, C., Polenta, B., Boscaro, M., & Arnaldi, G. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-101347 · Cited by 30
Lacroix, A., Gu, F., Schopohl, J., Kandra, A., Pedroncelli, A. M., Jin, L., & Pivonello, R. (2019) · Pituitary · doi:10.1007/s11102-019-01021-2 · Cited by 29
Rubinstein, G., Oßwald, A., Braun, L., Vogel, F., Kroiß, M., Pilz, S., Deniz, S., Aigner, L. I., Knösel, T., Bertherat, J. Y., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03020-z · Cited by 29
Vogel, F., Braun, L., Zopp, S., Nowak, E., Schreiner, J., Benz, I., Rubinstein, G., Künzel, H., Ritzel, K., Kroiss, M., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad041 · Cited by 28
Medical management of Cushing's disease: When and how?
Castinetti, F. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13120 · Cited by 28
Pituitary-Directed Therapies for Cushing’s Disease
Langlois, F., Chu, J. M., & Fleseriu, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00164 · Cited by 28
Management of adrenal incidentalomas: Working through uncertainty
Cambos, S., & Tabarin, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101427 · Cited by 28
Self-citationAdrenal incidentalomas: A guide to assessment, treatment and follow-up
Paschou, S. Α., Vryonidou, A., & Goulis, D. G. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.07.017 · Cited by 28
Hou, B., Gao, L., Shi, L., Luo, Y., Guo, X., Young, G. S., Qin, L., Zhu, H., Lü, L., Wang, Z., et al. (2020) · Journal of neurosurgery · doi:10.3171/2019.10.jns191400 · Cited by 28
Melson, E., Davitadze, M., Aftab, M., Ng, C. Y., Ooi, E., Blaggan, P., Chen, W., Hanania, T., Thomas, L., Zhou, D., et al. (2020) · BMC Medical Education · doi:10.1186/s12909-020-02190-6 · Cited by 28
The chronic syndromes after previous treatment of pituitary tumours
Romijn, J. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.84 · Cited by 28
(2022) · Case Reports in Endocrinology · doi:10.1155/7520 · Cited by 28
Papakokkinou, E., Piasecka, M., Carlsen, H. K., Chantzichristos, D., Olsson, D. S., Dahlqvist, P. M., Petersson, M., Berinder, K., Bensing, S., Höybye, C., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01158-z · Cited by 27
Yuen, K. C. J. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.06.012 · Cited by 27
Elenius, H., McGlotten, R., & Nieman, L. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad454 · Cited by 27
Self-citationMANAGEMENT OF ENDOCRINE DISEASE: Can we cure Cushing’s disease? A personal view
BERTAGNA, X. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0062 · Cited by 27
Adrenal Surgery for Cushing’s Syndrome
Dalmazi, G. D., & Reincke, M. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.004 · Cited by 27
Sarkis, P., Rabilloud, M., Lifante, J., Siamand, A., Jouanneau, E., Gay, E., Chaffanjon, P. C., Chabre, O., & Raverot, G. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.01.002 · Cited by 27
Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms
Guilmette, J. M., & Nosé, V. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.03.002 · Cited by 27
Laparoscopic partial adrenalectomy using near-infrared imaging: the initial experience
Tuncel, A., Balcı, M., Aykanat, C., Aslan, Y., Berker, D. S., & Güzel, Ö. (2019) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645706.2019.1691016 · Cited by 27
Glucocorticoids are active players and therapeutic targets in atherosclerotic cardiovascular disease
van der Sluis, R. J., & Hoekstra, M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110728 · Cited by 27
Lacroix, A., Bronstein, M. D., Schopohl, J., Delibaşı, T., Salvatori, R., Li, Y., Barkan, A., Suzaki, N., Tauchmanovà, L., Ortmann, C.-E., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01246-0 · Cited by 27
Ketoconazole in Cushing’s syndrome: a profile of its use
Shirley, M. (2021) · Drugs & Therapy Perspectives · doi:10.1007/s40267-020-00799-7 · Cited by 27
Outcomes of Pituitary Radiation for Cushing’s Disease
Ironside, N. T., Chen, C., Lee, C., Trifiletti, D. M., Vance, M. L., & Sheehan, J. P. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.002 · Cited by 27
Bunevičius, A., Sheehan, D. E., Vance, M. L., Schlesinger, D. J., & Sheehan, J. P. (2020) · Journal of neurosurgery · doi:10.3171/2019.12.jns192743 · Cited by 26
Is Follow-up of Adrenal Incidentalomas Always Mandatory?
Reimondo, G., Muller, A., Ingargiola, E., Puglisi, S., & Terzolo, M. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.1.26 · Cited by 26
Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease
Zhang, D., Damoiseaux, R. D., Babayan, L., Rivera-Meza, E. K., Yang, Y., Bergsneider, M., Wang, M. B., Yong, W. H., Kelly, K. A., & Heaney, A. P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa699 · Cited by 26
Second-Line Tests in the Diagnosis of Adrenocorticotropic Hormone-Dependent Hypercortisolism
Pinelli, S., Barbot, M., Scaroni, C. M., & Ceccato, F. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.6.521 · Cited by 26
Increased Mortality Persists after Treatment of Cushing’s Disease: A Matched Nationwide Cohort Study
Bengtsson, D., Ragnarsson, Ó., Berinder, K., Dahlqvist, P. M., Engström, B. E., Ekman, B., Höybye, C., Järås, J., Valdemarsson, S. V., Burman, P., et al. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac045 · Cited by 26
Pituitary incidentalomas: A guide to assessment, treatment and follow-up
Paschou, S. Α., Vryonidou, A., & Goulis, D. G. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.08.006 · Cited by 27
Advances in the Medical Treatment of Cushing Disease
Tritos, N. A., & Biller, B. M. K. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.05.003 · Cited by 26
Self-citationFontaine-Sylvestre, C., Guillon, L. L., Moumdjian, R. A., Berthelet, F., & Lacroix, A. (2020) · Pituitary · doi:10.1007/s11102-020-01097-1 · Cited by 26
Castro, M. A., Corrales, E. P., Millán, J. M. S., Rebolleda, G., Pian, H. G., Ruz‐Caracuel, I., Santos, G. D. L., Urzaiz, L. L., Escobar-Morreale, H. F., & Berrocal, V. R. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.11.001 · Cited by 26
Alba, E. L., Japp, E., Fernandez-Ranvier, G. G., Badani, K. K., Wilck, E. J., Ghesani, M. V., Wolf, A., Wolin, E. M., Corbett, V., Steinmetz, D., et al. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac073 · Cited by 26
Chiodini, I., Ramos-Rivera, A., Marcus, A. O., & Yau, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00382 · Cited by 25
Li, D., Zhang, C. D., Saini, J., Singh, S., Nathani, R., Thangamuthu, K., Suresh, M., Atkinson, E. J., Achenbach, S. J., Van Gompel, J., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad069 · Cited by 25
Roldán-Sarmiento, P., Lam-Chung, C. E., Hinojosa-Amaya, J. M., Morales-García, M., Guillén-Placencia, M. F., Pérez-Flores, G. E., León-Suárez, A., León-Domínguez, J., Balbuena-Álvarez, S., Nava de la Vega, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa774 · Cited by 25
Fleseriu, M., Pivonello, R., Newell-Price, J. D. C., Gadelha, M. R., Biller, B. M. K., Auchus, R. J., Feelders, R. A., Shimatsu, A., Witek, P., Bex, M., et al. (2025) · Pituitary · doi:10.1007/s11102-024-01471-3 · Cited by 26
Self-citationA comprehensive review of the new FIGO classification of ovulatory disorders
Balen, A. H., Tamblyn, J. A., Skorupskaite, K., & Munro, M. G. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae003 · Cited by 26
Multidisciplinary Team Care in Pituitary Tumours
Marques, P., Sagarribay, A., Tortosa, F., Neto, L. L., Ferreira, J. T., Subtil, J., Palha, A. M., Dias, D., & Sapinho, I. (2024) · Cancers · doi:10.3390/cancers16050950 · Cited by 25
CyberKnife Radiosurgery in the Multimodal Management of Patients with Cushing Disease
Moore, J. M., Sala, E., Amorin, A., Martinez, H., Bhowmik, A. C., Chang, S. D., Soltys, S. G., Harsh, G. R., & Katznelson, L. J. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.01.057 · Cited by 25
Cushing's syndrome – Disease monitoring: Recurrence, surveillance with biomarkers or imaging studies
Ragnarsson, Ó. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101382 · Cited by 25
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-08
- Volume
- 100
- Issue
- 8
- Pages
- 2807-2831
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4525003
- OpenAlex
- W2127952551
- Semantic Scholar
- 4d26bfff9a2f2ea132ea661d03d84dc8b2293884
- Cited by
- 1,270
- References
- 213
- Citations by year
- 2026: 99 · 2025: 120 · 2024: 104 · 2023: 117 · 2022: 148 · 2021: 169 · 2020: 116 · 2019: 112 · 2018: 116 · 2017: 83 · 2016: 75 · 2015: 6
- FWCI
- 80.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, hypercortisolism, surgical resection, bilateral adrenalectomy, radiotherapy, corticotropinoma, comorbidity management, treatment selection
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Cushing Syndrome, Endocrinology, Humans, Patient Care Planning, Pituitary Neoplasms, Recurrence, Remission Induction, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.